Editor profile
Senior Editor, Biotech & Life Sciences
Marc Dubois explores the frontiers of genomic editing, biopharmaceutical R&D, and precision medicine. He analyzes how life science innovation transforms therapeutic outcomes.
marc.dubois@medtechdaily.orgAccording to the latest forecast from Precedence Research, the global digital health market size is expected to reach $1.17 trillion by 2035, with a CAGR of 10.8%. Telemedicine, AI applications, and service models are reshaping the landscape of the healthcare industry.
The Business Research Company's latest report shows that the global medical device market is expected to achieve a CAGR of 9.2% from 2026 to 2030, with AI, digital health, and smart hospitals becoming the core growth drivers.
In early 2026, the U.S. FDA updated its general health and clinical decision support guidance, expanding the scope of low-risk digital health products, and plans to streamline software-related guidance while introducing a new AI framework, with far-reaching implications for the industry.
A new report from BCG and HealthKois highlights India's rising biotech innovation but warns that structural gaps in funding, clinical execution, and regulation could limit the country's ability to scale.
Medtronic completes acquisition of SPR Therapeutics, incorporating Sprint peripheral nerve stimulation devices into its neuromodulation product line, strengthening its position in the rapidly growing non-opioid pain treatment field.
Analyze the data privacy issues arising from the integration of wearable devices and medical records, discuss the gaps in HIPAA protection and the industry impact.
PanopticAI obtains FDA's second 510(k) for contactless respiratory rate monitoring; Coreline Soft partners with Mint Medical to advance lung cancer screening AI in Germany; AIRS Medical receives strategic investment to accelerate MRI innovation; QuantumTX and Kaopiz join forces to develop AI-driven preventive healthcare solutions.
Artificial intelligence is accelerating drug development for central nervous system diseases. Insilico Medicine and SK Biopharmaceuticals announced a collaboration to discover neuroimmune drug candidates using Insilico's Pharma.AI platform, with potential milestone payments of up to $2.5 billion.
Taiwan's Far Eastern Memorial Hospital emphasizes that digital tools should focus on enhancing patient care, rather than pursuing technology for its own sake. This philosophy provides an important reflection for the global healthcare technology industry.
According to a report by Growth Market Reports, the global capsule endoscopy system market is expected to grow from $1.09 billion in 2024 to $2.15 billion by 2033, at a compound annual growth rate of 8.2%. The rising incidence of gastrointestinal diseases, AI-assisted image analysis, and the demand for non-invasive diagnostics are the key driving factors.
ContrastConnect has released a best practices guide for remote imaging scheduling and EMR integration, reflecting the ongoing needs of healthcare institutions in imaging workflows, interoperability, and compliance automation, and also showing that Digital Health and AI Healthcare infrastructure are penetrating deeper into clinical operations.
A recent Nature review points out that mRNA technology is moving from a vaccine tool toward a broader therapeutic platform. As bottlenecks around delivery, immune silencing, and tissue targeting are being addressed, the industry is entering the “mRNA therapeutics 2.0” phase.